Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteomic approaches advancing targeted protein degradation
Gajanan Sathe, Gopal P. Sapkota
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 11, pp. 786-801
Open Access | Times Cited: 21

Showing 21 citing articles:

Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin–Proteasome system
Hanshu Xie, Chao Zhang
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116168-116168
Closed Access | Times Cited: 5
Unveiling the hidden interactome of CRBN molecular glues with chemoproteomics
Kheewoong Baek, Rebecca J. Metivier, Shourya S. Roy Burman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Small molecule targeted protein degradation via the UPS: venturing beyond E3 substrate receptors
Renyu Guo, Fukang Yang, Emily C. Cherney
RSC Medicinal Chemistry (2025)
Closed Access
Lycobetaine Has Therapeutic Efficacy in Lung Squamous Cell Carcinoma by Targeting USP32 to Trigger Ferroptosis
Shangping Xing, Hua Chai, Zhenlong Chen, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 163-163
Open Access
Application of Mass Spectrometry for the Advancement of PROTACs
Hao Yin, Baoshuang Zhang, Ruibing Chen
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116829-116829
Closed Access
Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3
Yuying Suo, Daohai Du, Chao Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4804-4818
Closed Access | Times Cited: 4
Screening for molecular glues – Challenges and opportunities
Geoffrey A. Holdgate, Catherine Bardelle, Sophia K. Berry, et al.
SLAS DISCOVERY (2023) Vol. 29, Iss. 2, pp. 100136-100136
Open Access | Times Cited: 10
Degradome analysis to identify direct protein substrates of small-molecule degraders
Marco Jochem, Anna Schrempf, Lina-Marie Wagner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective
Xiujin Chang, Fangui Qu, Chunxiao Li, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1727-1767
Closed Access | Times Cited: 2
Characterisation of high throughput screening outputs for small molecule degrader discovery
Lillie Bell, Catherine Bardelle, Martin J. Packer, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 5, pp. 100162-100162
Open Access | Times Cited: 2
Targeted dephosphorylation of TFEB promotes its nuclear translocation
Jin‐Feng Zhao, Natalia Shpiro, Gajanan Sathe, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110432-110432
Closed Access | Times Cited: 2
A novel lncRNA GM47544 modulates triglyceride metabolism by inducing ubiquitination-dependent protein degradation of APOC3
Qianqian Xiao, Luyun Wang, Jing Wang, et al.
Molecular Metabolism (2024) Vol. 88, pp. 102011-102011
Open Access | Times Cited: 2
Development of Novel Silicon-Based Hydrophobic Tags (SiHyT) for Targeted Proteins Degradation
Ma Lan, Kun Zhang, Ziqi Huang, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Blockade of the lncRNA-DOT1L-LAMP5 axis enhances autophagy and promotes degradation of MLL fusion proteins
Tian-Qi Chen, Heng‐Jing Huang, Shun-Xin Zhu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access | Times Cited: 1
Degradome analysis to identify direct protein substrates of small-molecule degraders
Marco Jochem, Anna Schrempf, Lina-Marie Wagner, et al.
Cell chemical biology (2024) Vol. 32, Iss. 1, pp. 192-200.e6
Open Access | Times Cited: 1
Bifunctional Compound for Targeted Degradation of the Immune Checkpoint Protein PD-L1
Congli Chen, Huaihuai Shi, Rui Hao, et al.
Acta Chimica Sinica (2024) Vol. 82, Iss. 6, pp. 613-613
Closed Access
Acetyl-CoA Carboxylase Proteolysis-Targeting Chimeras: Conceptual Design and Application as Insecticides
Qi Xu, Hao Feng, Zhong Li, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 34, pp. 18809-18815
Closed Access
Computational strategies for the design of proteolysis targeting chimera degraders: Artificial intelligence enabled PROTAC design
Rajamanikkam Kamaraj, Radim Nencka, Petr Pávek
Annual reports in medicinal chemistry (2024)
Closed Access
Protacs in cancer therapy: mechanisms, design, clinical trials, and future directions
Akash Vikal, Rashmi Maurya, Brij Bihari Patel, et al.
Drug Delivery and Translational Research (2024)
Closed Access
Advancing targeted protein degradation modalities
Jerry C. Madukwe
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 11, pp. 743-745
Open Access
Page 1

Scroll to top